Open Access

[Retracted] miR‑372 promotes breast cancer cell proliferation by directly targeting LATS2

  • Authors:
    • Xueyuan Cheng
    • Junqiang Chen
    • Zhong Huang
  • View Affiliations

  • Published online on: July 21, 2025     https://doi.org/10.3892/etm.2025.12926
  • Article Number: 176
  • Copyright : © Cheng et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

September-2025
Volume 30 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Cheng X, Chen J and Huang Z: [Retracted] miR‑372 promotes breast cancer cell proliferation by directly targeting LATS2. Exp Ther Med 30: 176, 2025.
APA
Cheng, X., Chen, J., & Huang, Z. (2025). [Retracted] miR‑372 promotes breast cancer cell proliferation by directly targeting LATS2. Experimental and Therapeutic Medicine, 30, 176. https://doi.org/10.3892/etm.2025.12926
MLA
Cheng, X., Chen, J., Huang, Z."[Retracted] miR‑372 promotes breast cancer cell proliferation by directly targeting LATS2". Experimental and Therapeutic Medicine 30.3 (2025): 176.
Chicago
Cheng, X., Chen, J., Huang, Z."[Retracted] miR‑372 promotes breast cancer cell proliferation by directly targeting LATS2". Experimental and Therapeutic Medicine 30, no. 3 (2025): 176. https://doi.org/10.3892/etm.2025.12926